Seatgeek and Forbes Cancelled

by | Jun 1, 2022

A combination of terminations and extensions as deal pressure intensifies.

————————————————-
Free Investor Resources from Boardroom Alpha
—————————————————-
** Podcast: Know Who Drives Return
** Daily SPAC Newsletter
** Full SPAC Listing

SPAC Deal: ATA – Rally

Americas Technology Acquisition Corp. (ATA) announces a DA with Rally, an “intercity transportation technology platform that harnesses the private bus industry to solve the challenges of middle-mile travelers.” The transaction values Rally at an enterprise value of $208M. Trust size $115M. No PIPE.

Seatgeek and Forbes deals terminated

  • RedBall Acquisition Corp.(RBAC) terminated its DA with ticket platform Seatgeek, citing “unfavorable market conditions”
  • Magnum Opus Acquisition Corp. (OPA) terminated its DA with digital publisher Forbes

ETAC extension vote

E.merge Technology Acquisition Corp. (ETAC) sets an extension vote for 6/28; 3 months (from August to November). SPAC adds $0.035 / month or ~$0.105 total. Current NAV $10.00.

NAAC postpones vote

North Atlantic Acquisition Corporation (NAAC) postpones vote. The SPAC’s primary focus is on the consumer, industrials and TMT sectors.  

INKA files for extension

KludeIn I Acquisition Corp. (INKA) files PRE14 for a 6-month extension from July to Jan. SPAC adds 3.3c / month and has a pending DA with data intelligence specialist Near.

Boardroom Alpha SPAC market review for May

Time is running out as SPACs scramble to finance deals at almost any cost. Expect more deSPAC duds as sponsors push low-quality companies at onerous valuations — for the simple purpose of protecting at-risk capital. Full report here.

Elsewhere in SPACs

SPAC votes this week

  • Thu: EDTX extension
  • Fri: SVFC / Symbotic

SPAC Calendar

Source: Boardroom Alpha

More from Boardroom Alpha

For ongoing tracking, analytics, and data on SPACs checkout Boardroom Alpha’s SPAC Data and Analytics service.

Recent Analysis

Daily SPAC Update – December 10, 2024

Jackson Acquisition II $200M IPO (Jackson I Liquidated). APXI Shareholders Approve Extension w/ 5M Redemptions. HCVI Merger Amendment. SLAMF Vote Adjourned and IVCB Vote Postponed. 

Daily SPAC Update – December 9, 2024

TCHP + Coincheck Deal Approved. GLLI, INAQ, ESHA Shareholders Approve Extensions. DP Cap Acquisition  (DPCS) Dismisses Accountant. SLAM and BRKH Extension Votes.

Daily SPAC Update – December 4, 2024

Global Star (GLST) Extension Approved. APXI Extension Vote Today. ATMC Updates Trust Numbers. LATG Deal Vote Set for Dec 23. ATMV, SHAP, TRON, INAQ Set Extension Votes.

Subscribe to Boardroom Alpha Newsletters

Subscribe to Boardroom Alpha's research to receive the latest on governance, SPACs, and people.

Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon. 

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.  

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by BA that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.  

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.